Table 2 Reporting of treatment use by study type
From: Treatment use in prognostic model research: a systematic review of cardiovascular prognostic studies
| Reported treatment | Overall (n = 302) (%)a | Development studies (n = 124) (%) | Incremental value studies (n = 135) (%) | Validation studies (n = 146) (%) |
|---|---|---|---|---|
| Medication use (any) | 135 (45) | 45 (36) | 73 (54) | 62 (41) |
| Antihypertensive | 122 (41) | 40 (32) | 66 (49) | 58 (38) |
| Lipid-lowering | 81 (27) | 24 (19) | 47 (33) | 38 (26) |
| Antithrombotic/anticoagulant | 17 (6) | 2 (2) | 15 (11) | 7 (5) |
| Lifestyle interventions | 2 (1) | 1 (1) | 0 | 1 (1) |
| Surgical interventions | 39 (13) | 9 (7) | 26 (19) | 15 (11) |